Janus kinase 2
Last updated 18 Aug 2020
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
The JAK2 gene provides instructions for making a protein that promotes the growth and division (proliferation) of cells. This protein is part of a signaling pathway called the JAK/STAT pathway, which transmits chemical signals from outside the cell to the cell's nucleus. The JAK2 protein is especially important for controlling the production of blood cells from hematopoietic stem cells. These stem cells are located within the bone marrow and have the potential to develop into red blood cells, white blood cells, and platelets.
Video picks for GenesVideo library
Normal function
The JAK2 gene provides instructions for making a protein that promotes the growth and division (proliferation) of cells. This protein is part of a signaling pathway called the JAK/STAT pathway, which transmits chemical signals from outside the cell to the cell's nucleus. The JAK2 protein is especially important for controlling the production of blood cells from hematopoietic stem cells. These stem cells are located within the bone marrow and have the potential to develop into red blood cells, white blood cells, and platelets.
Conditions referring to this gene or chromosome
Other names
JAK-2
JAK2_HUMAN
Janus kinase 2 (a protein tyrosine kinase)
JTK10
tyrosine-protein kinase JAK2
Patient picks for Genes

Chest and lungs
When do I need a chest X-Ray if I have a cough?
Dr Sarah Jarvis MBE The doctor will want to know how long your cough has lasted and whether you have any other symptoms. The doctor will particularly ask about symptoms which may suggest an underlying serious condition ('red flags'). [https://patient.info/health/cough-leaflet#nav-2](https://patient.info/health/cough-leaflet#nav-2)
by Dr Sarah Jarvis

Hay fever
How do hay fever tablets work?
Dr Sarah Jarvis MBE If your hay fever symptoms are not controlled on the medication that you are taking after 2-4 weeks, you should discuss this with your doctor. You may need to try a different treatment or add in another treatment. If you are taking hay fever medication regularly and your hay fever is well controlled on your current treatment, you should continue this treatment until the end of the pollen season. [https://patient.info/health/hay-fever-leaflet#nav-5](https://patient.info/health/hay-fever-leaflet#nav-5)
by Dr Sarah Jarvis

Video
What are the different kinds of vulvar problems?
Dr Lesley Regan There are many different conditions that can affect your vulva, ranging from mild infections to skin conditions and, very rarely, to cancer. They can all cause very different symptoms, including itching, bleeding, rashes or a lump. It is very important that if you notice any new symptoms or lumps in your vulval region then you see a doctor promptly. Your doctor will be able to examine you and decide which treatment will be appropriate to you. This will depend on the underlying cause of your symptoms. https://patient.info/health/vulval-problems-leaflet#nav-2
by Prof Lesley Regan, FRCOG

PID Q&A
How do you contract PID?
Dr Sarah Jarvis MBE It is not known how many women develop PID each year, and it is probably often not picked up. It most commonly develops in women aged between 15 and 24 years. [https://patient.info/health/pelvic-pain-in-women/pelvic-inflammatory-disease#nav-2](https://patient.info/health/pelvic-pain-in-women/pelvic-inflammatory-disease#nav-2)
by Dr Sarah Jarvis

Diabetes Q&A
How do you get tested for type 2 diabetes?
Dr Sarah Jarvis MBE It is now recommended that the blood test for HbA1c can also be used as a test to diagnose type 2 diabetes. An HbA1c value of 48 mmol/mol (6.5%) or above is recommended as the blood level for diagnosing diabetes. In many cases type 2 diabetes is diagnosed during a routine medical or when tests are done for an unrelated medical condition. For more information on type 2 diabetes, go to [https://patient.info/health/type-2-diabetes](https://patient.info/health/type-2-diabetes)
by Dr Sarah Jarvis

Video
Lust or Bust I The Sex and Relationships Podcast I S1E7
If sex is another job on the ‘to do’ list, and you find you’re losing sexual attraction for your partner, it’s time to press the Reset button. Clare and Janet chat about why we ‘go off it’ and how we can get it back! Dip into some of things Clare and Janet chat about in this episode: 5:03 How to prioritise your relationship and not take each other for granted. 06:24 How to stop feelings of being taken for granted and resentment building up 11:23 Attitudes towards sex in long term relationships 20’53 How to manage sexual disappointment 24:32 How to negotiate mismatch desire. 28:06 Don’t rush to break up when lust and sexual attraction leave the room. Staying in a relationship can reap benefits beyond imagination. 33:01 Clare and Janet’s top tips Want to know more? If you want to hear more about sexual attraction listen to episode 2 The Arousal Paradox: [https://www.youtube.com/watch?v=c2tzDBBF1vc](https://www.youtube.com/watch?v=c2tzDBBF1vc) Visit our website The Sex and Relationships Podcast for more information on the issues discussed in this episode: [https://thesexandrelationshipspodcast.com/](https://thesexandrelationshipspodcast.com/) You can also Ask Clare a question or suggest a topic for future episodes. Follow us on social media: Instagram: [https://www.instagram.com/s3x_and_relationships_podcast/profilecard/?igsh=MXIza3BxeWg3OTJxOA%3D%3D](https://www.instagram.com/s3x_and_relationships_podcast/profilecard/?igsh=MXIza3BxeWg3OTJxOA%3D%3D) Facebook: [https://www.facebook.com/people/The-Sex-and-Relationships-Podcast-With-Therapists-Clare-Janet/61558082319934/](https://www.facebook.com/people/The-Sex-and-Relationships-Podcast-With-Therapists-Clare-Janet/61558082319934/) About The Sex and Relationships Podcast: This podcast is for anyone looking for information or help with their sex lives or relationships. Your hosts Clare Prendergast and Janet Eccles are sex and relationship therapists. In each episode they chat about common problems they see in the therapy room and draw on their years of experience to give you some insights, advice and top tips to help guide you through your relationships and sex lives.
Related patient information and medicines

Patient information leaflet
Myelofibrosis
Myelofibrosis is a condition affecting the bone marrow ... The gene mutation that occurs in most people affected by myelofibrosis is a mutation in Janus Kinase 2 (JAK2). Dr Sarah Jarvis, December 2021 NICE guidance on drug treatments for myelofibrosis Fedratinib for treating disease-related splenomegaly or symptoms in myelofibrosis The National.

Patient information leaflet
Pompholyx
Pompholyx is a type of eczema where there are itchy blisters on the hands and feet, followed by inflamed and dry skin. The condition is usually... Dapilumab : this medication is used for a type of eczema called atopic dermatitis. In some cases it has been shown to be helpful for the treatment of pompholyx. Janus Kinase (JAK) inhibitors : these.

Patient information leaflet
Juvenile idiopathic arthritis
As they are relatively new medicines, there are still studies being done to establish whether there are any long-term health risks from taking them. Options include: Etanercept Etanercept Tocilizumab Infliximab Abatacept Adalimumab Tofacitinib is another new drug. It belongs to a type of drug called JAK kinase inhibitors. It is sometimes used if.

Patient information leaflet
Primary liver cancer
It is not likely to be curative for primary liver cancer but may shrink the tumour down to slow the progression of the disease. There are new medicines being developed for the treatment of liver cancer. For example, sorafenib is a type of medicine called a multi-targeted kinase inhibitor. It interferes with the growth of cancer cells. Research has.

Patient information leaflet
Mouth cancer
Epidermal growth factor receptor monoclonal antibody (EGFR mAb) is one form of targeted therapy. Cetuximab is an EGFR mAb. Tyrosine kinase inhibitors (TKIs) are another. Immunotherapy is treatment that aims to boost the body's own immune system to destroy the cancer cells. It is also sometimes called biological therapy: Recombinant interleukin.

Patient information leaflet
Muscular dystrophy
Also, if a child has delayed motor milestones (as mentioned above), a doctor may advise testing for MD, even though the problem could be due to another cause. MD may be diagnosed using one or more of the following tests: A blood test Blood tests for creatine kinase (CK) - in many types of MD, the blood level of CK is very high. A muscle biopsy.
Further reading and references
- Janus kinase 2; MedlinePlus, National Library of Medicine.
- Basquiera AL, Soria NW, Ryser R, Salguero M, Moiraghi B, Sackmann F, Sturich AG, Borello A, Berretta A, Bonafe M, Barral JM, Palazzo ED, Garcia JJ. Clinical significance of V617F mutation of the JAK2 gene in patients with chronic myeloproliferative disorders. Hematology. 2009 Dec;14(6):323-30. doi: 10.1179/102453309X12473408860226.
- James C. The JAK2V617F mutation in polycythemia vera and other myeloproliferative disorders: one mutation for three diseases? Hematology Am Soc Hematol Educ Program. 2008:69-75. doi: 10.1182/asheducation-2008.1.69.
- Patel RK, Lea NC, Heneghan MA, Westwood NB, Milojkovic D, Thanigaikumar M, Yallop D, Arya R, Pagliuca A, Gaken J, Wendon J, Heaton ND, Mufti GJ. Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the Budd-Chiari syndrome. Gastroenterology. 2006 Jun;130(7):2031-8. doi: 10.1053/j.gastro.2006.04.008.
- Spivak JL. Narrative review: Thrombocytosis, polycythemia vera, and JAK2 mutations: The phenotypic mimicry of chronic myeloproliferation. Ann Intern Med. 2010 Mar 2;152(5):300-6. doi: 10.7326/0003-4819-152-5-201003020-00008.
- Tefferi A. Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1. Leukemia. 2010 Jun;24(6):1128-38. doi: 10.1038/leu.2010.69. Epub 2010 Apr 29.
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

